Candidate-gene studies of the atherogenic lipoprotein phenotype: A sib- pair linkage analysis of DZ women twins

American Journal of Human Genetics

Volumn 62, Issue 2, 1998, Pages 406-419

  Austin, Melissa A ^a,e   Talmud, Philippa J ^b   Luong, Le Ahn ^b   Haddad, Lema ^b   Day, Ian N M ^b   Newman, Beth ^c   Edwards, Karen L ^a   Krauss, Ronald M ^d   Humphries, Steve E ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c University of North Carolina ^*  (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN RECEPTOR; LIPID TRANSFER PROTEIN; LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DIZYGOTIC TWINS; FEMALE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; SIBLING; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0031886107     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301712     Document Type: Article

References (64)

1. Amos CI (1988) Robust method for detection of genetic linkage for data from extended families and pedigrees. PhD dissertation, Louisana State University Medical Center, New Orleans
2. Austin MA (1991) Triglycerides and coronary heart disease. Arterioscler Thromb 11:2-14
3. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WS, Krauss RM (1988a) Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921
4. Austin MA, Brunzell JD, Fitch WL, Krauss RM (1990a) Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 10: 520-530
5. Austin MA, Hokanson JE, Brunzell JD (1994) Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 5: 395-403
6. Austin MA, Jarvik GP, Hokanson JE, Edwards KL (1993d) Complex segregation analysis of LDL peak particle diameter. Genet Epidemiol 10:599-604
7. Austin MA, King M-C, Bawol RD, Hulley SB, Friedman GD (1987) Risk factors for coronary heart disease in adult female twins: genetic heritability and shared environmental influences. Am J Epidemiol 125:308-318
8. Austin MA, King M-C, Vranizan KM, Krauss RM (1990b) Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 82: 495-506
9. Austin MA, King M-C, Vranzian KM, Newman B, Krauss RM (1988b) Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet 43:838-846
10. Austin MA, Krauss RM (1995) LDL density and atherosclerosis. JAMA 273:115
11. Austin MA, Newman B, Selby JV, Edwards KL, Mayer EJ, Krauss RM (1993b) Genetics of LDL subclass phenotypes in women twins: concordance, heritability and commingling analysis. Arterioscler Thromb 13:687-695
12. Austin MA, Wijsman E, Guo S, Krauss RM, Brunzell JB, Deeb S (1991) Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia. Genet Epidemiol 8:287-297
13. Bhattacharya S, Ameis D, Cullen P, Norcisi TM, Bayliss J, Greten H, Schotz MC, et al (1991) VNTR polymorphism in the hepatic lipase gene (LIPC). Nucleic Acids Res 19:5088
14. Blackwelder, Elston RC (1982) Power and robustness of sibpair linkage tests and extension to larger sibships. Communications Stat Theor Methods 11:449-484
15. Boerwinkle E, Xiong W, Fourest E, Chan L (1989) Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci USA 86:212-216
16. Bolla MJ, Haddad L, Humphries SE, Winder AF, Day INM (1995) High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis and microplate diagonal gel electrophoresis. Clin Chem 41:1599-1604
17. Bredie SJH, Kiemeney LA, de Haan AFJ, Demacker PNM, Stalenhoef AFH (1996) Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia. Am J Hum Genet 58:812-822
18. Cullen P, Farren B, Scott J, Farrall M (1994) Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler Thromb 14: 1233-1249
19. Dammerman M, Sandkuijl LA, Hlaas JL, Chung W, Breslow JL (1993) An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphism. Proc Natl Acad Sci USA 90:4562-4566
20. Day INM, Haddad L, O'Dell SD, Day LB, Whittall RA, Humphries SE (1997) Identification of a common low density lipoprotein receptor mutation (R329X) in the south of England: complete linkage disequilibrium with an allele of microsatellite D19S394. J Med Genet 34:111-116
21. de Graaf J, Swinkels DW, de Haan AFJ, Demakher PNM, Stalenhoef AFH (1992) Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families. Am J Hum Genet 51:1295-1310
22. Friedewald WT, Levy FI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without preparatory ultracentrifugation. Clin Chem 18:499-502
23. Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Nguyen TD, Gleeson A, et al (1994) Apolipoprotein-B structure and receptor recognition of triglyceride-rich low-density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem 269:511-519
24. Gardner CD, Fortmann SP, Krauss RM (1996) Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276: 875-881
25. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52:1544-1568
26. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J (1994) Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106:241-253
27. Haffner SM, Mykkanen L, Valdez RA, Paidi M, Stern MP, Howard BV (1993) LDL size and subclass pattern in a biethnic population. Arterioscler Thromb 13:1623-1630
28. Haffner SM, Stern MP, Miettinen H, Robbins D, Howard BV (1996) Apolipoprotein E polymorphism and LDL size in a biethnic population. Arterioscler Thromb Vasc Biol 16: 1184-1188
29. Haseman JK, Elston RC (1972) The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 2:3-19
30. Hokanson JE, Austin MA (1996) Plasma triglyceride level is an independent risk factor for cardiovascular disease: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219
31. Humphries SE, Fisher R, Mailly F, Talmud P, Karpe F, Hamsten A, Miller G (1996) Gene-environment interaction in determining plasma lipids and dietary response: the effect of common mutations in the gene for lipoprotein lipase (D9N and N291S). In: Bray GA, Rayn DH (eds) Nutrition, genetics and heart disease. Vol 6 in: Pennington Center nutrition series. Louisana State University Press, Baton Rouge, pp 279-295
32. Humphries SE, Peacock RE, Talmud PJ (1995) The genetic determinants of plasma cholesterol and response to diet. In: Betteridge JB (ed) Clinical endocrinology and metabolism: international practise and research. Ballieire-Tindall, London, pp 797-824
33. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL (1990) Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249:790-793
34. Jamil H, Gordon DA, Eustice DC, Brooks CM, Dickson JK Jr, Chen Y, Chu CH, et al (1996) An inhibitor of the microsomal triglyceride transfer protein inhibits apo B section from HepG2 cells. Proc Natl Acad Sci USA 93:11991-11995
35. Krauss RM, Burke DJ (1982) Identification of multiple subclasses of plasma low-density lipoproteins in normal humans. J Lipid Res 23:97-104
36. LaBelle M, Austin MA, Rubin E, Krauss RM (1991) Linkage analysis of low-density lipoprotein subclass phenotypes and the apolipoprotein B locus. Genet Epidemiol 8:269-275
37. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després J-P (1997) Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 95:69-75
38. Lamon-Fava, Jimienez D, Christian JC, Fabstiz RR, Reed T, Carmelii D, Castelli WP, et al (1991) The NHLBI twin study: heritability of apolipoprotein A-I and B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis 91:97-106
39. Levitt RC, Jedlicka AE, Nouri N (1992) Dinucleotide repeat polymorphism at the hormone sensitive lipase (LIPE) locus. Hum Mol Genet 1:139
40. McNamara JR, Jenner JL, Li Z, Wilson PW, Schaefer EJ (1992) Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thomb 12: 1284-1290
41. Mullenbach R, Lagoda PJL, Welter C (1989) Technical tips: an efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 5:391
42. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W (1984) Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Biochem 22:165-174
43. Narcisi TME, Shoulders CC, Chester SA, Read J, Brett DJ, Harrison GB, Grantham TT, et al (1995) Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. Am J Hum Genet 57:1298-1310
44. Nichols AV, Krauss RM, Muliner TA (1986) Nondenaturing polyacrylamide gradient gel electrophoresis. In: Preparation, structure and molecular biology. Part A in: Segrest JP, Albers JJ (eds) Plasma lipoproteins. Vol 128 in: Methods in enzymology. Academic Press, Orlando, pp 417-431
45. NIH Consensus Development Panel on Triglyceride, High Density Lipoprotein, and Coronary Heart Disease (1993) Triglyceride, high density lipoprotein and coronary heart disease. JAMA 269:505-510
46. Nishina PM, Johnson JP, Naggert JK, Krauss RM (1992) Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci USA 89:708-712
47. Oucherony O, Nilsson LQ (1978) Immunodiffusion and immunoelectrophoresis. In: Weir DM (ed) Handbook of experimental immunology. Blackwell Scientific, Oxford, pp 19.10-19.13
48. Rifai N, King ME (1986) Immunoturbidimetric assay of apolipoproteins (a), AI, All and B in serum. Clin Chem 32: 957-961
49. Rotter JI, Bu X, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ, et al (1996) Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet 58:585-594
50. SAGE (1994) Statistical analysis for genetic epidemiology, release 2.2. Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
51. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389
52. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM (1993) LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88: 381-387
53. Sharp DB, Kienzle B, Li MCM, Wetterau JR (1994) Human microsomal triglyceride transfer protein large subunit structure. Biochemistry 33:9057-9061
54. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301-1307
55. Shimada F, Makino H, Hashimoto N, Iwaoka H, Taira M, Nozaki O, Kanatsuki A, et al (1996) Detection of an amino acid polymorphism in hormone-sensitive-lipase in Japanese subjects. Metabolism 45:862-864
56. Smith SJ, Cooper GR, Henderson LO, Hannon WH (1987) An international collaborative study on standardization of apolipoproteins AI and B. I. Evaluation of lyophilized candidate reference calibrators. Clin Chem 33:2240-2249
57. Stampfer MJ, Krauss RM, Elance PJ, Holl LG, Sacks FM, Hennekens CH (1996) A prospective study of triglyceride level, low-density lipoprotein particle diameter and risk of myocardial infarction. JAMA 276:882-915
58. Talmud PJ, Ye S, Humphries S, European Atherosclerosis Group (1994) A polymorphism in the promoter of the apolipoprotein AI gene associated with differences in APO AI levels: the European Atherosclerosis Research Study. Genet Epidemiol 11:265-280
59. Thomson G, Motro U (1994) Affected sib pair identity by state analysis. Genet Epidemiol 11:353-364
60. Warnick GR, Nguyen TT, Albers AA (1985) Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Cin Chem 31:217-222
61. Xiang K, Granquist M, Seino M, Seino S, Bell GI (1991) Microsatellite polymorphism in human insulin receptor gene (INSR) on chromosome 19. Nucleic Acids Res 19:5094
62. Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J (1995) An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet 95:371-375
63. Zuliani G, Hobbs HH (1990a) Tetranucleotide repeat polymorphism in the apolipoprotein B gene. Nucleic Acids Res 18:4299
64. _ (1990b) Tetranucleotide repeat polymorphism in the apolipoprotein CIII gene. Nucleic Acids Res 18:4299